States With Abortion Bans Also Saw Declines in Birth Control Post-Dobbs
By Ernie Mundell HealthDay Reporter
WEDNESDAY, June 26, 2024 -- Post-Dobbs bans and restrictions on abortion are having a spillover effect in reducing the use of birth control and emergency contraception in those states most affected, a new study shows.
Why the troubling trend? The study's author believes the demise of Roe v. Wade in 2022 triggered the closure of many family planning clinics.
“Because 11% of women rely on such clinics for the provision of prescriptions for contraceptives -- many of which are filled at outside pharmacies -- these closures may have reduced access to oral and emergency contraceptives,” explained study lead author Dr. Dima Qato. She's an associate professor of clinical pharmacy at the University of Southern California (USC).
Qato's team relied on three main sources to gauge trends in prescriptions for birth control and emergency contraception (for example, the "morning after" pill), looking at uptake between March 2021 and October 2023.
The sources were the IQVIA National Prescription Audit PayerTrak, which tracks the monthly volume of prescriptions dispensed at pharmacies; the 2021 American Community Survey, to determine the total population of women and girls of reproductive age; and the Guttmacher Institute, which classified each state in terms of changes in policies related to abortion.
Over the study period, nearly 143 million prescriptions for oral contraceptive pills were written, as well as more than 904,000 prescriptions for emergency contraceptives.
Before the July 2022 overturning of Roe v. Wade, states had similar rates of dispensing these prescriptions, Qato's group found.
But after the landmark Supreme Court decision, states that then restricted access to abortion saw a 24% average decline in birth control pill prescriptions and a 65% drop in prescriptions for emergency contraception.
“We saw the greatest declines in birth control pills and emergency contraceptives in states that had closed a larger share of their family planning clinics," noted study co-author Rebecca Myerson, an assistant professor of population health sciences at the University of Wisconsin, Madison.
"In Texas, for example, birth control pill prescriptions declined by 28% and emergency contraceptive fills declined by 48%,” Myerson said in a USC news release.
The researchers pointed to another possible reason contraception might have declined in the wake of the Dobbs decision: Confusion and misunderstandings among women living in certain states as to whether contraception might also be banned or restricted.
They cited a January 2023 survey by the Kaiser Family Foundation which found that half of women living in states with full bans on abortion believed the "morning after" pill, Plan B, was also now illegal.
The findings were published June 26 in the journal JAMA Network Open.
Sources
- University of Southern California, news release, June 26, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Human Fertility Levels Need To Be Higher To Avoid Extinction
THURSDAY, May 1, 2025 — Billionaire and Tesla CEO Elon Musk has made headlines with dire warnings that declining birth rates are an “existential crisis” for...
Some OB/GYNS Stay in States With Abortion Bans, Despite Legal Risks
WEDNESDAY, April 23, 2025 — Three years after the U.S. Supreme Court ended the federal right to abortion, doctors who specialize in obstetrics and gynecology are still...
Federal Prosecutor Questions Medical Journals Over Alleged Bias
WEDNESDAY, April 23, 2025 — At least three medical journals have received letters from a top federal prosecutor questioning whether they mislead readers or allow political...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.